a

argenx
ARGX

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
€32.46B
EV
€29.23B
Shares Outstanding
63.33M
Beta
0.20

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
€684.19
P/E 2025E
47.11x
P/Revenue 2025E
9.75x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About argenx SE

gainify

a

argenx SE

ARGX

argenx SE, a biotechnology company, engages in the developing of various therapies for the treatment of autoimmune diseases in the United States, Japan, Europe, Middle East, Africa, and China. Its lead product candidate is efgartigimod for the treatment of patients wi...

Sector

Healthcare

Industry

Biotechnology

CEO

Van Hauwermeiren, Timothy

Employees

1,599

IPO Date

2014-07-10

Headquarters

Laarderhoogtweg 25, Amsterdam, Noord-Holland, 1101EB, Netherlands

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved